How should I conduct a comprehensive assessment for Alzheimer's disease and Parkinson's disease in an older adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Conducting Alzheimer's and Parkinson's Disease Assessments

For Alzheimer's disease assessment, obtain a structured history from both patient and informant covering cognition, activities of daily living, mood/neuropsychiatric symptoms, and sensorimotor function, followed by validated cognitive testing (e.g., Montreal Cognitive Assessment with cutoff ≤14 or Thai Mental State Examination with cutoff ≤25), Tier 1 laboratory panel (CBC, comprehensive metabolic panel, TSH, B12, homocysteine, CRP, ESR), and brain MRI to establish the three-step diagnostic formulation: cognitive functional status, cognitive-behavioral syndrome, and etiologic diagnosis 1. For Parkinson's disease assessment, focus on motor examination for cardinal features (tremor at rest, bradykinesia, rigidity, postural instability) while recognizing that cognitive screening cutoffs differ from Alzheimer's disease 2.

Alzheimer's Disease Assessment Framework

Step 1: Structured History Taking (The Foundation)

From the Patient AND Informant - this is non-negotiable 1:

  • Cognitive changes: Memory (short-term vs long-term), language difficulties, executive dysfunction, visuospatial problems
  • Functional impact:
    • Basic ADLs (bathing, dressing, toileting, feeding)
    • Instrumental ADLs (medication management, finances, driving, cooking, shopping)
  • Neuropsychiatric symptoms: Depression, apathy, irritability, anxiety, agitation, hallucinations, delusions
  • Sensorimotor function: Gait changes, falls, tremor, weakness

Critical temporal elements to establish:

  • Sequential order of symptom onset
  • Frequency and tempo of progression
  • Relationship between events and symptoms
  • Impact on daily function and safety

Step 2: Risk Factor Assessment 1

Document individualized risk profile:

  • Modifiable factors: Hypertension, diabetes, obesity, hearing loss, smoking, physical inactivity, social isolation, depression
  • Non-modifiable: Age, family history, APOE genotype (if known)
  • Resilience factors: Education level, cognitive reserve, social engagement

Step 3: Cognitive Testing 1

Use validated instruments - interpretation requires profile analysis, not just cutoff scores:

  • Montreal Cognitive Assessment (MoCA): Cutoff ≤14 for differentiating Parkinson's disease dementia from Parkinson's disease (sensitivity 81.1%, specificity 75%) 2
  • Thai Mental State Examination: Cutoff ≤25 (sensitivity 78.4%, specificity 66.7%) 2
  • Mini-Mental State Examination: Traditional but less sensitive for mild impairment

Important caveats:

  • Scores must be interpreted with patient's education, language, culture, and sensory impairments in mind
  • If validated brief tests are insufficient (extremes of age/education, complex demographics), refer to neuropsychology 1
  • Memory and language deficits distinguish Alzheimer's from Parkinson's disease dementia 2

Step 4: Laboratory Testing (Tier 1 - Mandatory for All) 1

Order this "cognitive lab panel" universally:

  • Complete blood count with differential
  • Comprehensive metabolic panel (Chem-20): renal/hepatic function, electrolytes, glucose, calcium, magnesium, phosphate
  • Thyroid-stimulating hormone (TSH)
  • Vitamin B12 level
  • Homocysteine level
  • C-reactive protein (CRP)
  • Erythrocyte sedimentation rate (ESR)

Rationale: These identify common comorbid conditions that contribute to (rarely cause) cognitive symptoms and are nearly universally recommended by specialty societies 1.

Step 5: Structural Brain Imaging 1

MRI is preferred; if unavailable or contraindicated, obtain CT:

  • Exclusionary purpose: Rule out tumor, infarct, neuroinflammatory/infectious lesions
  • Inclusionary purpose: Identify regional atrophy patterns
    • Hippocampal/medial temporal atrophy suggests Alzheimer's disease
    • Frontal/temporal atrophy suggests frontotemporal dementia
    • Absence of atrophy does NOT exclude underlying pathology

Step 6: Establish Three-Step Diagnostic Formulation 1

  1. Cognitive functional status: Normal, subjective decline, mild cognitive impairment, or dementia (mild/moderate/severe)
  2. Cognitive-behavioral syndrome: Amnestic, dysexecutive, behavioral variant, language variant, visuospatial, or mixed 1
  3. Etiologic diagnosis: Alzheimer's disease, vascular, Lewy body, frontotemporal, or mixed pathology

Critical consideration: In adults >80 years, multiple pathologies are the rule, not the exception 1. Identify the primary driver while acknowledging contributors.

Parkinson's Disease Assessment Framework

Step 1: Motor Examination - The Core

Assess the four cardinal features:

  1. Resting tremor: 4-6 Hz, pill-rolling, asymmetric, disappears with movement
  2. Bradykinesia: Slowness of movement, reduced amplitude with repetitive movements (finger tapping, hand opening/closing)
  3. Rigidity: Lead-pipe or cogwheel, tested passively at wrist, elbow, neck
  4. Postural instability: Pull test (stand behind patient, pull shoulders backward - abnormal if >2 steps or would fall without catching)

Modified Hoehn and Yahr staging 2:

  • Stage 1: Unilateral involvement
  • Stage 2: Bilateral involvement without balance impairment
  • Stage 2.5: Mild bilateral with recovery on pull test
  • Stage 3: Mild-moderate bilateral, postural instability, physically independent
  • Stage 4: Severe disability, still able to walk/stand unassisted
  • Stage 5: Wheelchair-bound or bedridden

Step 2: Cognitive Assessment in Parkinson's Disease

Critical distinction: Cognitive screening cutoffs for Parkinson's disease dementia differ from Alzheimer's disease 2:

  • MoCA cutoff ≤14 (NOT the standard ≤26) to differentiate Parkinson's disease dementia from Parkinson's disease without dementia
  • TMSE cutoff ≤25 for same purpose
  • Cognitive profile: Parkinson's disease dementia shows less severe memory and language deficits compared to Alzheimer's disease, with more prominent executive dysfunction 2

Step 3: Distinguish Parkinsonism from Parkinson's Disease

Parkinsonism = motor syndrome (tremor, rigidity, bradykinesia, postural instability)

Parkinson's disease = specific neurodegenerative disorder with Lewy body pathology

Key clinical differentiators:

  • Parkinson's disease: Asymmetric onset, good levodopa response, resting tremor prominent
  • Vascular parkinsonism: Lower body predominant, stepwise progression, poor levodopa response, MRI shows cerebrovascular disease 3
  • Drug-induced: Symmetric, history of dopamine-blocking medications
  • Progressive supranuclear palsy: Early falls, vertical gaze palsy, axial rigidity 1
  • Multiple system atrophy: Autonomic failure, cerebellar signs, poor levodopa response

Important finding: In older adults with parkinsonism but no clinical Parkinson's disease, only 7% have Lewy body pathology at autopsy, while 70% show cerebrovascular pathologies 3. This means most late-life parkinsonism is vascular, not prodromal Parkinson's disease.

Step 4: Assess for Dementia in Parkinson's Disease

Parkinson's disease dementia criteria 1:

  • Established Parkinson's disease diagnosis
  • Cognitive decline sufficient to impair daily function
  • Deficits in ≥2 cognitive domains
  • Typically occurs >1 year after motor symptoms (if <1 year, consider dementia with Lewy bodies)

Neuropsychiatric features to assess:

  • Visual hallucinations (common in Lewy body disorders)
  • REM sleep behavior disorder
  • Fluctuating cognition
  • Depression and apathy

Common Pitfalls and How to Avoid Them

For Alzheimer's Assessment:

  1. Relying on patient report alone: Always obtain informant history - patients often lack insight or minimize symptoms 1
  2. Using single cutoff scores: Interpret the cognitive test profile, not just pass/fail 1
  3. Missing depression as early Alzheimer's symptom: >50% of those who develop dementia had depression/irritability beforehand 1
  4. Assuming normal MRI excludes Alzheimer's: Absence of atrophy doesn't exclude pathology 1

For Parkinson's Assessment:

  1. Using Alzheimer's cognitive cutoffs: MoCA ≤14 (not ≤26) differentiates Parkinson's disease dementia from Parkinson's disease 2
  2. Assuming all parkinsonism is Parkinson's disease: In older adults, cerebrovascular disease causes most parkinsonism 3
  3. Overlooking visual impairment: Parkinson's disease affects contrast sensitivity, which can worsen cognitive test performance independent of true cognitive decline 4
  4. Missing atypical presentations: Symmetric onset, poor levodopa response, early falls, or prominent autonomic symptoms suggest alternative diagnoses 1

For Both:

  1. Ignoring sensory impairments: Hearing loss and vision problems affect test performance and are dementia risk factors 5
  2. Single-disease thinking: Adults >80 typically have multiple pathologies contributing to symptoms 1
  3. Skipping functional assessment: Cognitive scores without functional impact assessment miss the clinical significance 1

When to Refer

Neuropsychology referral indicated when 1:

  • Extremes of age, education, or intelligence
  • Complex medical/demographic considerations
  • Language/cultural barriers
  • Validated brief tests insufficient or inconclusive
  • Discrepancy between subjective complaints and objective testing

Neurology/Movement Disorder specialist referral:

  • Atypical features suggesting non-Parkinson's disease parkinsonism
  • Rapid progression
  • Poor response to levodopa trial
  • Diagnostic uncertainty
  • Complex medication management needs

References

5
Guideline

clinician's guide to geriatric assessment.

Mayo Clinic Proceedings, 2024

Related Questions

In an 81-year-old female with dementia who fell backward and struck the back of her head, with stable vital signs, normal point‑of‑care glucose and a normal electrocardiogram, what is the differential diagnosis and what workup—including laboratory studies, imaging, and immediate interventions—should be performed?
What is the diagnostic approach for tremor in older adults?
What is the appropriate evaluation and management of hand shaking (tremor) in a patient with Alzheimer’s disease?
What is the appropriate diagnostic and management approach for an elderly female presenting with head nodding?
What diagnostic workup and likely diagnoses should be considered for an elderly adult who has been confined to bed for several days?
What medication combinations are most effective for rapid control of acute agitation, psychosis, or mania in the emergency setting?
What is the significance of white exudate seen on endoscopy of the ascending colon and how should incidentally discovered diverticulosis in that area be managed?
In an 87‑year‑old woman with left hip pain and a possible impacted femoral neck fracture on X‑ray, left ventricular hypertrophy on ECG, markedly elevated NT‑proBNP, normal troponin I, elevated C‑reactive protein and D‑dimer, and low‑normal vitamin D, what are the likely diagnoses and recommended management?
What is the most appropriate antihistamine for severe pruritus in a generally healthy adult?
In a 50‑year‑old woman with unexplained lip swelling and laboratory findings of hyponatremia, hypokalemia, high‑anion‑gap metabolic acidosis, elevated liver enzymes, microcytic anemia with low iron, leukocytosis with neutrophilia, low vitamin D, and abnormal glucose and lipid panels, which diagnostic tests should be obtained to evaluate the cause of the angioedema?
How should a resident manage bacterial meningitis in the ICU, including empiric antibiotics, adjunctive steroids, supportive care, and monitoring for complications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.